{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK7",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "PARK7 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PARK7 DJ-1 have been associated with autosomal-recessive early-onset Parkinson's disease (PD). Functional DJ-1 is a dimer that acts as an atypical peroxiredoxin-like peroxidase, a regulator of transcription, and a chaperone. DJ-1 missense mutations may lead to a 'gain-of-function' behavior through pathological protein-protein interactions.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism for PARK7/DJ-1 in PD as involving loss of protective functions and potential gain-of-function through altered protein interactions, which is relevant to the functional assays described."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses yeast two-hybrid screening, co-immunoprecipitation, and cell viability/apoptosis assays (MTT, PARP cleavage, caspase 3 activation) in neuroblastoma cells to assess protein interactions and cellular effects of DJ-1 mutants under proteasome impairment.",
          "judgment": "Yes",
          "reasoning": "These assays (protein interaction and cell-based apoptosis assays) are relevant to PD pathogenesis as they model protein misfolding, aggregation, and neuronal cell death, which are central to the disease mechanism involving DJ-1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Controls include wild-type DJ-1 and empty vector controls in co-immunoprecipitation and apoptosis assays. Experiments were repeated in duplicate or more, and for stably transfected cells, at least two independent clones were used for each cell line.",
          "judgment": "Yes",
          "reasoning": "The paper includes both normal (wild-type DJ-1) and negative (empty vector) controls. It also explicitly states the use of replicates (duplicates or more) and multiple independent clones, satisfying the criteria for basic controls and replicates.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study compares M26I and L166P (PD-associated mutants) with wild-type DJ-1 in interaction and apoptosis assays. Both mutants are known pathogenic variants associated with PD.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (M26I and L166P) are used as controls in the assays, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analysis was performed using Student's t-test, with significance reported (e.g., P<0.002 for apoptosis assays). Data represent mean ± S.D., but no direct OddsPath calculation or equivalent quantitative measure for pathogenicity likelihood is provided.",
          "judgment": "No",
          "reasoning": "While statistical tests are reported, there is no direct calculation or estimation of OddsPath or a comparable quantitative measure for pathogenicity likelihood from the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses two PD-associated variants (M26I and L166P) as controls in the assays related to protein interaction and apoptosis.",
          "judgment": "10 or less",
          "reasoning": "Only two pathogenic variant controls (M26I and L166P) are used across the study, which is less than 11, limiting the strength of evidence.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for PARK7 M26I is rated as PS3_supporting due to the use of relevant assays demonstrating stronger interaction with TTRAP and inhibition of TTRAP's anti-apoptotic activity, leading to increased cell death via JNK and p38-MAPK pathways. However, the limited number of variant controls (less than 11) restricts the strength to supporting."
    },
    {
      "variant_id": {
        "Gene": "PARK7",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "PARK7 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PARK7 DJ-1 have been associated with autosomal-recessive early-onset Parkinson's disease (PD). Functional DJ-1 is a dimer that acts as an atypical peroxiredoxin-like peroxidase, a regulator of transcription, and a chaperone. DJ-1 missense mutations may lead to a 'gain-of-function' behavior through pathological protein-protein interactions.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism for PARK7/DJ-1 in PD as involving loss of protective functions and potential gain-of-function through altered protein interactions, which is relevant to the functional assays described."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses yeast two-hybrid screening, co-immunoprecipitation, and cell viability/apoptosis assays (MTT, PARP cleavage, caspase 3 activation) in neuroblastoma cells to assess protein interactions and cellular effects of DJ-1 mutants under proteasome impairment.",
          "judgment": "Yes",
          "reasoning": "These assays (protein interaction and cell-based apoptosis assays) are relevant to PD pathogenesis as they model protein misfolding, aggregation, and neuronal cell death, which are central to the disease mechanism involving DJ-1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Controls include wild-type DJ-1 and empty vector controls in co-immunoprecipitation and apoptosis assays. Experiments were repeated in duplicate or more, and for stably transfected cells, at least two independent clones were used for each cell line.",
          "judgment": "Yes",
          "reasoning": "The paper includes both normal (wild-type DJ-1) and negative (empty vector) controls. It also explicitly states the use of replicates (duplicates or more) and multiple independent clones, satisfying the criteria for basic controls and replicates.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study compares M26I and L166P (PD-associated mutants) with wild-type DJ-1 in interaction and apoptosis assays. Both mutants are known pathogenic variants associated with PD.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (M26I and L166P) are used as controls in the assays, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analysis was performed using Student's t-test, with significance reported (e.g., P<0.002 for apoptosis assays). Data represent mean ± S.D., but no direct OddsPath calculation or equivalent quantitative measure for pathogenicity likelihood is provided.",
          "judgment": "No",
          "reasoning": "While statistical tests are reported, there is no direct calculation or estimation of OddsPath or a comparable quantitative measure for pathogenicity likelihood from the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses two PD-associated variants (M26I and L166P) as controls in the assays related to protein interaction and apoptosis.",
          "judgment": "10 or less",
          "reasoning": "Only two pathogenic variant controls (M26I and L166P) are used across the study, which is less than 11, limiting the strength of evidence.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for PARK7 L166P is rated as PS3_supporting due to the use of relevant assays demonstrating stronger interaction with TTRAP and inhibition of TTRAP's anti-apoptotic activity, leading to increased cell death via JNK and p38-MAPK pathways. However, the limited number of variant controls (less than 11) restricts the strength to supporting."
    }
  ]
}